Efficacy and Safety of IdegLira versus Basal-Bolus Insulin Therapy in Patients with type 2 Diabetes Uncontrolled on Metformin and Basal Insulin; DUAL VII Randomized Clinical Trial

Billings LK, Doshi A, Gouet D, Oviedo A, Rodbard HW, Tentolouris N, et al.
Diabetes Care. 2018 Feb 26. pii: dc171114.
http://doi.org/10.2337/dc17-1114
Ver comentario
Comentado por el Dr. Rodrigo Ibaceta Watson. Residente Nutrición y Diabetes Adultos, Pontificia Universidad Católica de Chile.

Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures.
Cassatella D, Howard SR, Acierno JS, Xu C, Papadakis GE, Santoni FA et al.
Eur J Endocrinol. 2018 Apr;178(4):377-388.
http://dx.doi.org/10.1530/EJE-17-0568
Epub 2018 Feb 1